---
schema_version: "secwatch.filing_event.v1"
accession: "0001062993-24-008687"
form_type: "8-K"
ticker: "ZSTK"
cik: "0001790169"
company_name: "ZeroStack Corp."
filed_at: "2024-04-23T23:59:59+00:00"
generated_at: "2026-06-03T12:10:01.165683+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Flora Growth completes first closing of TruHC Pharma acquisition; issues 2.14M shares worth ~$4.9M

## Summary
- First closing of TruHC Pharma GmbH acquisition; issued 2,135,199 common shares.
- Shares valued at $2.31/share (March 28 close); first closing = 19.99% of pre-signing outstanding.
- Second closing of 635,363 shares pending shareholder approval at next meeting.
- Total acquisition consideration: 2,770,562 shares valued at ~$6.4 million.

## SEC filing metadata
- accession: 0001062993-24-008687
- form_type: 8-K
- ticker: ZSTK
- cik: 0001790169
- company_name: ZeroStack Corp.
- filed_at: 2024-04-23T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1790169/000106299324008687/0001062993-24-008687-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1790169/000106299324008687/form8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001062993-24-008687
- JSON: https://secwatch.observer/filing/0001062993-24-008687.json
- Plain text: https://secwatch.observer/filing/0001062993-24-008687.txt

## Key facts
- M&A Transactions
  ZeroStack Corp. completed an acquisition involving TruHC Holding GmbH for $6.4 million (closed 2024-04-22).
  - Action: acquisition
  - Counterparty: TruHC Holding GmbH
  - Consideration: $6.4 million
  - Closing: 2024-04-22
  source text: On April 22, 2024, Flora Growth Corp. (the "Company") completed the first closing (the "First Closing") of the previously disclosed acquisition of TruHC Pharma GmbH in exchange for a total of 2,770,562 common shares of the Company valued at an aggregate of $6.4 million based on the closing price of the Company's common shares on March 28, 2024 of $2.31 per share
  evidence_url: https://www.sec.gov/Archives/edgar/data/1790169/000106299324008687/0001062993-24-008687-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.